Panorama Capital

Panorama Capital invests across the full lifecycle of private company growth, from seed and start-up stages through expansion and late-stage rounds. This multi-stage approach allows the firm to back companies early and continue supporting them as they scale. The strategy is designed to capture value at multiple points of the growth curve.

Panorama Capital is structured as a third-party asset manager, not a single-family office. It operates as a private equity firm raising capital from external institutional and qualified investors. The firm's Shanghai headquarters and China-focused mandate position it as a domestic fund manager.

Based on its stated investment stages, Panorama Capital primarily executes direct equity investments into companies rather than making fund commitments. The firm's stage coverage from seed to growth suggests a direct-investment model. Details on any fund-of-funds activity are not publicly available.

Panorama Capital's deal flow likely originates through founder networks, co-investor relationships, and the broader Shanghai venture ecosystem. As a generalist technology investor, the firm would evaluate opportunities across China's major startup hubs. Specific sourcing channels are not disclosed publicly.

No public record specifically identifies sectors that Panorama Capital explicitly avoids. Its stage-agnostic, general venture mandate suggests a broad aperture toward technology-enabled businesses. The firm likely screens out sectors inconsistent with Chinese regulatory frameworks, as is standard practice for onshore managers.

Panorama Capital does not publicly name its investment committee members or key decision-makers. The firm's website and public record do not identify managing partners, founders, or senior investment staff. This opacity is not unusual among smaller private Chinese fund managers.

Panorama Capital likely participates in syndicated rounds alongside other venture and growth-stage firms, as its multi-stage model would require collaboration for larger transactions. Direct co-investment rights alongside external GPs are not publicly documented. The firm's standard practices on co-investment allocation remain undisclosed.